Transplant Rejection Clinical Trial
Official title:
Immunological Mechanisms of Rejection in Uterine Transplantation
The objective of this study is to understand the mechanisms of rejection in uterine transplantation and to search for non-invasive markers of rejection. The biological samples necessary for our research have been or will be collected during procedures (biopsies, smears, vaginal swab, blood tests) carried out as part of the scheduled follow-up of patients. These will be samples whose collection is minimally or not invasive
In the context of uterine transplantation, non-invasive rejection markers will be sought by different approaches, including transcriptomics on a prospective cohort of patients with different types of samples: blood, smear and biopsy. A microbiota study will also be carried out. 3 groups will be studied: 1 group of 10 patients benefiting or having benefited from a uterine transplant, 1 second group made up of their 10 donors, 1 group of 10 control women ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03984747 -
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection
|
||
| Completed |
NCT04046549 -
A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant
|
Phase 2 | |
| Completed |
NCT01338779 -
Study of Tolerant Kidney Transplant Recipients
|
N/A | |
| Recruiting |
NCT05156710 -
BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)
|
Phase 2 | |
| Completed |
NCT03582436 -
Rejection Diagnosis in Kidney Transplants Patients
|
||
| Completed |
NCT01766050 -
Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers
|
Phase 4 | |
| Completed |
NCT01236378 -
Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients
|
Phase 1 |